tiprankstipranks
Avicanna (TSE:AVCN)
TSX:AVCN

Avicanna (AVCN) Stock Price & Analysis

14 Followers

AVCN Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.23 - C$0.60
Previous CloseC$0.36
Volume133.03K
Average Volume (3M)108.28K
Market Cap
C$31.57M
Enterprise ValueC$36.90M
Total Cash (Recent Filing)C$718.29K
Total Debt (Recent Filing)C$2.13M
Price to Earnings (P/E)-3.8
Beta-0.13
May 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding87,687,800
10 Day Avg. Volume123,372
30 Day Avg. Volume108,278
Standard Deviation0.29
R-Squared0.06
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-51.48
Price to Sales (P/S)8.68
Price to Cash Flow (P/CF)N/A
P/FCF Ratio92.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

26.20%0.00%0.01%73.79%
26.20% Insiders
0.01% Other Institutional Investors
73.79% Public Companies and
Individual Investors

AVCN FAQ

What was Avicanna’s price range in the past 12 months?
Avicanna lowest stock price was C$0.23 and its highest was C$0.60 in the past 12 months.
    What is Avicanna’s market cap?
    Currently, no data Available
    When is Avicanna’s upcoming earnings report date?
    Avicanna’s upcoming earnings report date is May 27, 2024 which is in 28 days.
      How were Avicanna’s earnings last quarter?
      Avicanna released its earnings results on Apr 02, 2024. The company reported -C$0.028 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.028.
        Is Avicanna overvalued?
        According to Wall Street analysts Avicanna’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Avicanna pay dividends?
          Avicanna does not currently pay dividends.
          What is Avicanna’s EPS estimate?
          Avicanna’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Avicanna have?
          Avicanna has 87,687,800 shares outstanding.
            What happened to Avicanna’s price movement after its last earnings report?
            Avicanna reported an EPS of -C$0.028 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.547%.
              Which hedge fund is a major shareholder of Avicanna?
              Currently, no hedge funds are holding shares in TSE:AVCN
              ---

              Avicanna Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Avicanna

              Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and R&D With two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna has engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto.
              ---

              AVCN Earnings Call

              Q4 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Avicanna
              IM Cannabis Corp
              Histogen
              MariMed
              Aclaris Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis